drugset / Trial / NCT00133380

A Study in People With High Cholesterol

NCT00133380 ↗

Phase 2 Completed 300 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The purposes of this study are to determine: * The safety of the study medication and any side effects that might be associated with it * Whether the study medication can help patients with high levels of "bad" cholesterol (low-density lipoprotein-cholesterol \[LDL-C\]), alone or in combination with additional study medication

Timeline

Start
2005-07
Primary completion
—
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg —
Subject Atorvastatin Small molecule 40 mg —
Subject LY518674 Small molecule 10 ug —
Subject LY518674 Small molecule 50 ug —

Indications